- Active ingredient
- palivizumab
- Strength
- 100 mg/ml
- Form
- vial
- Manufacturer
- abbvie ltd. > multipharma
- Route
- injection
Uses
Used to prevent serious lower respiratory tract disease caused by RSV in high-risk infants and young children, including premature infants and certain patients with bronchopulmonary dysplasia or significant congenital heart disease.
Do not use if
Previous significant hypersensitivity reaction to palivizumab or any component of the product.
Side effects
Fever, rash, injection-site reactions, and hypersensitivity reactions may occur. Rarely, severe allergic reactions including anaphylaxis can occur.
Warnings
Severe hypersensitivity and anaphylaxis may occur. Discontinue permanently if a serious allergic reaction develops.
How it works
Humanized monoclonal antibody with activity against respiratory syncytial virus, used for passive immunization.
Storage
Store refrigerated at 2–8°C in the original container. Do not freeze.
